2‐Amino thiazole derivatives as inhibitors of some metabolic enzymes: An in vitro and in silico study. (27th July 2022)

• Record Type: Journal Article
• Authors: Korkmaz, Işıl Nihan
• Is Part Of: Biotechnology and applied biochemistry. Volume 70:Number 2(2023)
• Page Start: 659
• Page End: 669
• Publication Date: 2022-07-27
• Subjects: carbonic anhydrase -- cholinesterase -- inhibition -- molecular docking -- thiazole; Biotechnology -- Periodicals; Biochemical engineering -- Periodicals; Biochemistry -- Periodicals; Biochemistry -- Periodicals; Genetic Techniques -- Periodicals; Microbiological Techniques -- Periodicals; 660.6
• DOI: 10.1002/bab.2388
• Languages: English
• ISSNs: 0885-4513

Abstract

Abstract: The thiazole derivatives are desirable compounds in the evaluation of their biological activities such as antiprotozoal antibacterial, antifungal, antituberculosis. Considering the medical application potential of 2‐amino thiazole compounds, we aimed to determine the effects of 2‐amino thiazole derivatives on the activities of carbonic anhydrase I–II isoenzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the chemicals we used in our study, 2‐amino‐4‐(4‐chlorophenyl)thiazole compound exhibited the best inhibition against hCA I with Ki of 0.008 ± 0.001 μM. The 2‐amino‐4‐(4‐bromophenyl)thiazole compound exhibited the best inhibition against hCA II, AChE, and BChE with Ki of 0.124 ± 0.017, 0.129 ± 0.030, and 0.083 ± 0.041 μM, respectively. Molecular docking analysis showed that compound 2‐amino‐4‐(5, 6, 7, 8‐tetrahydro‐2‐naphthyl)thiazole had the highest inhibitory potency against hCA I, hCA II, AChE, BChE with the estimated binding energy of −6.75, −7.61, −7.86, −7.96 kcal/mol, respectively.